Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,564
Total Claims
$2.0M
Drug Cost
804
Beneficiaries
$2,453
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-79%
Opioid rate vs peers
0.5% vs 2.2% avg
+74%
Cost per patient vs peers
$2,453 vs $1,411 avg
+24%
Brand preference vs peers
13.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.5%
Opioid Rate
55
Opioid Claims
$222
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,507 claims · $1.7M
Generic: 9,938 claims · $284K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 208 | $302K |
| Dulaglutide | 114 | $243K |
| Empagliflozin | 84 | $120K |
| Rivaroxaban | 68 | $90K |
| Semaglutide | 42 | $87K |
| Sitagliptin Phosphate | 52 | $87K |
| Dapagliflozin Propanediol | 58 | $74K |
| Fluticasone/Umeclidin/Vilanter | 50 | $60K |
| Insulin Degludec | 43 | $47K |
| Sacubitril/Valsartan | 18 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 40 | $35K |
| Linagliptin | 32 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $28K |
| Insulin Aspart | 20 | $26K |
| Umeclidinium Brm/Vilanterol Tr | 31 | $25K |
Prescribing Profile
Patient Profile
72
Avg Age
63%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About